SELF |
Amid Growing Health Concerns, FDA Recommends Opioid Pulled From Market
Anesthesiology News The FDA has asked Endo Pharmaceuticals to remove an opioid pain medication, reformulated extended-release oxymorphone hydrochloride (Opana ER), from the market due to "concern that the benefits of the drug may no longer outweigh its risks.". The FDA Has Asked a Drugmaker to Take This Opioid Off the Market FDA shocks lawmakers by pulling opioid off the market FDA wants to yank an opioid painkiller over concerns about abuse |
from Health - Google News http://ift.tt/2slIgWj
EmoticonEmoticon